Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX)
$0.67
+0.0159 ( +2.43% ) 32.5K
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Market Data
Open
$0.67
Previous close
$0.65
Volume
32.5K
Market cap
$2.67M
Day range
$0.66 - $0.68
52 week range
$0.57 - $12.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Oct 30, 2023 |
4 | Insider transactions | 1 | Oct 30, 2023 |
4 | Insider transactions | 1 | Oct 30, 2023 |
4 | Insider transactions | 1 | Oct 30, 2023 |
8-k | 8K-related | 13 | Sep 13, 2023 |
def | Proxies and info statements | 6 | Sep 12, 2023 |
ars | Annual reports | 1 | Sep 12, 2023 |
pre | Proxies and info statements | 6 | Sep 01, 2023 |
10-q | Quarterly Reports | 70 | Aug 03, 2023 |
8-k | 8K-related | 14 | Aug 02, 2023 |